Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma

Dermatologic Surgery

Volumn 36, Issue 3, 2010, Pages 368-376

  Brewer, Jerry D ^a   Christenson, Leslie J ^a   Weenig, Roger H ^a   Weaver, Amy L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; METASTASIS; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 77749267588     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2009.01447.x     Document Type: Article

References (44)

1. Hu S, Federman DG, Ma F, Kirsner RS. Skin cancer and non-Hodgkin's lymphoma: examining the link. Dermatol Surg 2005 31 : 76 82.
2. Jemal A, Tiwari RC, Murray T, et al. American Cancer Society. Cancer statistics, 2004. CA Cancer J Clin 2004 54 : 8 29.
3. Tashima CK. Association of malignant melanoma and malignant lymphoma. Lancet 1973 2 : 266.
4. Adami J, Frisch M, Yuen J, et al. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 1995 310 : 1491 1495.
5. Riou JP, Ariyan S, Brandow KR, Fielding LP. The association between menaloma, lymphoma, and other primary neoplasms. Arch Surg 1995 130 : 1056 1061.
6. Levi F, Randimbison L, Te VC, La Vecchia C. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996 74 : 1847 1850.
7. Gutman M, Cnaan A, Inbar M, et al. Are malignant melanoma patients at higher risk for a second cancer? Cancer 1991 68 : 660 665.
8. Travis LB, Curtis RE, Boice JD Jr., et al. Second cancers following non-Hodgkin's lymphoma. Cancer 1991 67 : 2002 2009.
9. Travis LB, Curtis RE, Hankey BF, Fraumeni JF Jr. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1992 84 : 1422 1427.
10. Travis LB, Curtis RE, Glimelius B, et al. Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 1993 85 : 1932 1937.
11. McMichael AJ, Giles GG. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer 1996 73 : 945 950.
12. Hall P, Rosendahl I, Mattsson A, Einhorn S. Non-Hodgkin's lymphoma and skin malignancies - shared etiology? Int J Cancer 1995 62 : 519 522.
13. McKenna DB, Stockton D, Brewster DH, Doherty VR. Evidence of an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer 2003 88 : 74 8.
14. Kawakami Y, Eliyahu S, Delgado CH, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994 91 : 3515 3519.
15. Halliday GM, Patel A, Hunt MJ, et al. Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+T cells. World J Surg 1995 19 : 352 358.
16. Clemente CG, Mihm MC Jr., Bufalino R, et al. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996 77 : 1303 1310.
17. Menzies SW, McCarthy WH. Complete regression of primary cutaneous malignant melanoma. Arch Surg 1997 132 : 553 556.
18. Marshall JA, Forster TH, Purdie DM, et al. Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma. Immunol Cell Biol 2006 84 : 295 302.
19. Kipps TJ. Chronic lymphocytic leukemia. Curr Opin Hematol 2000 7 : 223 234.
20. Balch CM, Soong SJ, Atkins MB, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 2004 54 : 131 149.
21. Greene MH, Hoover RN, Fraumeni JF Jr. Subsequent cancer in patients with chronic lymphocytic leukemia: a possible immunologic mechanism. J Natl Cancer Inst 1978 61 : 337 340.
22. Griffiths RW, Briggs JC. Long term follow-up in cutaneous malignant melanoma: the relationship of maximal tumour thickness to disease free survival, disease recurrence and death. Br J Plast Surg 1984 37 : 507 513.
23. Urist MM, Balch CM, Soong S, et al. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer 1985 55 : 1398 1402.
24. Veronesi U, Cascinelli N. Narrow excision (1-cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg 1991 126 : 438 441.
25. Ringborg U, Andersson R, Eldh J, et al. Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group. Cancer 1996 77 : 1809 1814.
26. Karakousis CP, Balch CM, Urist MM, et al. Local recurrence in malignant melanoma: long-term Results of the multiinstitutional randomized surgical trial. Ann Surg Oncol 1996 3 : 446 452.
27. Cohn-Cedermark G, Rutqvist LE, Andersson R, et al. Long term Results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm. Cancer 2000 89 : 1495 1501.
28. Ng AK, Jones WO, Shaw JH. Analysis of local recurrence and optimizing excision margins for cutaneous melanoma. Br J Surg 2001 88 : 137 142.
29. Balch CM, Soong SJ, Investigators from the Intergroup Melanoma Surgical Trial et al. Long-term Results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol 2001 8 : 101 108.
30. Khayat D, Rixe O, French Group of Research on Malignant Melanoma. et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer 2003 97 : 1941 1946.
31. Rodrigues LK, Klencke BJ, Vin-Christian K, et al. Altered clinical course of malignant melanoma in HIV-positive patients. Arch Dermatol 2002 138 : 765 770.
32. Greene MH, Young TI, Clark WH Jr. Malignant melanoma in renal-transplant recipients. Lancet 1981 1 : 1196 1199.
33. Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996 61 : 274 278.
34. Lévêque L, Dalac S, Dompmartin A, et al. Melanoma in organ transplant patients [French]. Ann Dermatol Venereol 2000 127 : 160 165.
35. Le Mire L, Hollowood K, Gray D, et al. Melanomas in renal transplant recipients. Br J Dermatol 2006 154 : 472 477.
36. Dapprich DC, Weenig RH, Rohlinger AL, et al. Outcomes of melanoma in recipients of solid organ transplant. J Am Acad Dermatol 2008 59 : 405 417.
37. Matin RN, Mesher D, Skin Care in Organ Transplant Patients, Europe (SCOPE) group et al. Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant 2008 8 : 1891 1900.
38. Mehrany K, Byrd DR, Roenigk RK, et al. Lymphocytic infiltrates and subclinical epithelial tumor extension in patients with chronic leukemia and solid-organ transplantation. Dermatol Surg 2003 29 : 129 134.
39. Aslakson CJ, Lee G, Boomer JS, et al. Expression of regeneration and tolerance factor on B cell chronic lymphocytic leukemias: a possible mechanism for escaping immune surveillance. Am J Hematol 1999 61 : 46 52.
40. Cantwell M, Hua T, Pappas J, Kipps TJ. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Nat Med 1997 3 : 984 989.
41. Lacombe C, Gombert J, Dreyfus B, et al. Heterogeneity of serum IgG subclass deficiencies in B chronic lymphocytic leukemia. Clin Immunol 1999 90 : 128 132.
42. Mehrany K, Weenig RH, Pittelkow MR, et al. High recurrence rates of squamous cell carcinoma after Mohs' surgery in patients with chronic lymphocytic leukemia. Dermatol Surg 2005 31 : 38 42. (Pubitemid 40094060)
43. Mehrany K, Weenig RH, Pittelkow MR, et al. High recurrence rates of basal cell carcinoma after Mohs surgery in patients with chronic lymphocytic leukemia. Arch Dermatol 2004 140 : 985 988.
44. Mehrany K, Weenig RH, Lee KK, et al. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. J Am Acad Dermatol 2005 53 : 1067 1071. (Pubitemid 41677335)